** Shares of Integral Diagnostics IDX.AX fall 29% to A$2.030, their lowest levels since February 20, 2024
** Stock is currently the top loser on ASX All Ordinaries Index .AORD
** The medical imaging services provider reports HY loss attributable of A$396,000 ($251,420.40), compared with a loss of A$66.8 million last year
** Co also reports HY operating NPAT of A$9.8 million, missing consensus estimate of A$11.1 million
** Expects replacement and growth capex for FY25 to be between A$60 million and A$65 million
** About 4.9 million shares change hands, 5.6 times the 30-day average of 870,753
** Stock down 28.9% YTD, including current session's moves
($1 = 1.5751 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。